Tanvex BioPharma (6541.TW) Q2 2026 Earnings

12MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.62
-1.45
-1.27
-1.1

Details

Expected EPS
-1.62102211352
Actual EPS
-1.45298933346
Surprise EPS
0.17
Surprise Percent
+10.37%

Description

Tanvex BioPharma (6541.TW) has reported earnings of -1.45298933346 per share for Q2 2026.

0 Comments

Share your thoughts